Press Releases

Memorial Sloan Kettering Cancer Center (MSK) has again been recognized among the nation’s very best, earning the distinction as the top cancer center i...

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Joan Massagué Awarded Kennedy Award from the Institu...

Memorial Sloan Kettering Cancer Center (MSK) announced the appointment of Martin R. Weiser, MD, as Chair of the Department of Surgery, effective i...

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Eric H. Bent, Joseph Chan, Alessandro Di Federi...

Results from EMERALD-3, a global phase 3 clinical trial, show that adding immunotherapy alongside a commonly utilized liver-directed procedure significantly delayed cancer progression in patients whose liver cancer has spread or cannot be treated with surgery.

An oral targeted therapy is showing promise for people with dedifferentiated liposarcoma (DDLPS), a rare subtype of soft tissue sarcoma, according to Memorial Sloan Kettering Cancer Center (MSK) physician-scientists. Results from the long awaited SARC041 phase 3 clinical trial were presented today at the annual American Society of Clinical Oncology (ASCO) meeting.

Memorial Sloan Kettering Cancer Center today announced that Shakeeb Akhter has joined MSK as its new Chief Digital Officer.